Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy

NCT05865301 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT05865301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05865301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy
Lead sponsor
Stanford University
Phase
Observational
Overall status
Recruiting
Start date
June 29, 2023
Completion date
December 31, 2038
Enrollment
500 (estimated)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoid leukemia